LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Three new companies spring to life from boron research at RTP-based Boragen
Research Triangle Park-based Boragen to be split into three different companies, one focused on crop protection, one on animal health, and the other on human health.